User profiles for author:Thomas author:P author:Burris

Thomas P Burris

Alumni Endowed Professor of Pharmacology, Washington University School of Medicine …
Verified email at wustl.edu
Cited by 12589

Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA

…, P Huang, Y Hamuro, S Raghuram, Y Wang, TP Burris… - Nature, 2008 - nature.com
Nuclear receptors are multi-domain transcription factors that bind to DNA elements from
which they regulate gene expression. The peroxisome proliferator-activated receptors
(PPARs) form heterodimers with the retinoid X receptor (RXR), and PPAR-γ has been …

Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ

…, LL Burris, S Khorasanizadeh, TP Burris… - Nature Structural and …, 2007 - nature.com
The nuclear receptors REV-ERBα (encoded by NR1D1) and REV-ERBβ (NR1D2) have
remained orphans owing to the lack of identified physiological ligands. Here we show that
heme is a physiological ligand of both receptors. Heme associates with the ligand-binding …

Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis

…, H Gao, TP Ryan, XC Jiang, TP Burris… - Journal of Biological …, 2003 - ASBMB
The oxysterol receptors LXR (liver X receptor)-α and LXRβ are nuclear receptors that play a
key role in regulation of cholesterol and fatty acid metabolism. We found that LXRs also play
a significant role in glucose metabolism. Treatment of diabetic rodents with the LXR agonist …

Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand

…, J Xu, G Wagoner, PD Drew, PR Griffin, TP Burris - Nature, 2011 - nature.com
T-helper cells that produce interleukin-17 (TH 17 cells) are a recently identified CD4+ T-cell
subset with characterized pathological roles in autoimmune diseases 1, 2, 3. The nuclear
receptors retinoic-acid-receptor-related orphan receptors α and γt (RORα and RORγt …

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

…, JS Takahashi, AA Butler, TM Kamenecka, TP Burris - Nature, 2012 - nature.com
Synchronizing rhythms of behaviour and metabolic processes is important for cardiovascular
health and preventing metabolic diseases. The nuclear receptors REV-ERB-α and REV-
ERB-β have an integral role in regulating the expression of core clock proteins driving …

A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis

…, PO Browne, O Rajanayagam, TP Burris… - Journal of Biological …, 2000 - ASBMB
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) promotes
adipocyte differentiation, exerts atherogenic and anti-inflammatory effects in monocyte/
macrophages, and is believed to mediate the insulin-sensitizing action of antidiabetic …

The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor (s) necessary for transcriptional silencing.

A Baniahmad, X Leng, TP Burris, SY Tsai… - … and cellular biology, 1995 - Am Soc Microbiol
The C terminus of nuclear hormone receptors is a complex structure that contains multiple
functions. We are interested in the mechanism by which thyroid hormone converts its
receptor from a transcriptional silencer to an activator of transcription. Both regulatory …

Regulation of carbohydrate metabolism by the farnesoid X receptor

…, T Cook, ME Christe, LF Michael, TP Burris - …, 2005 - academic.oup.com
The farnesoid X receptor (FXR; NR1H4) is a nuclear hormone receptor that functions as the
bile acid receptor. In addition to the critical role FXR plays in bile acid metabolism and
transport, it regulates a variety of genes important in lipoprotein metabolism. We …

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions

…, NY Chirgadze, Y Wang, TP Burris… - Proceedings of the …, 2003 - National Acad Sciences
The interaction between nuclear receptors and coactivators provides an arena for testing
whether protein–protein interactions may be inhibited by small molecule drug candidates.
We provide evidence that a short cyclic peptide, containing a copy of the LXXLL nuclear …

T0901317 is a dual LXR/FXR agonist

…, JS Thomas, KS Bramlett, LF Michael, TP Burris - Molecular genetics and …, 2004 - Elsevier
We characterize the ability of the liver X receptor (LXRα [NR1H3] and LXRβ [NR1H2])
agonist, T0901317, to activate the farnesoid X receptor (FXR [NR4H4]). Although T0901317
is a much more potent activator of LXR than FXR, this ligand actually activates FXR more …